Core Laboratories N.V. – NYSE:CLB
Core Laboratories N.V. stock price today
$10.46
-6.27
-37.51%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Core Laboratories N.V. stock price monthly change
-23.14%
month
Core Laboratories N.V. stock price quarterly change
-23.14%
quarter
Core Laboratories N.V. stock price yearly change
-10.00%
year
Core Laboratories N.V. key metrics
Market Cap | 802.14M |
Enterprise value | 959.50M |
P/E | 25.78 |
EV/Sales | 1.83 |
EV/EBITDA | 13.45 |
Price/Sales | 1.50 |
Price/Book | 3.13 |
PEG ratio | -1.18 |
EPS | 0.89 |
Revenue | 511.07M |
EBITDA | 73.00M |
Income | 41.78M |
Revenue Q/Q | 0.99% |
Revenue Y/Y | 1.64% |
Profit margin | 5.83% |
Oper. margin | 10.9% |
Gross margin | 17.56% |
EBIT margin | 10.9% |
EBITDA margin | 14.28% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCore Laboratories N.V. stock price history
Core Laboratories N.V. stock forecast
Core Laboratories N.V. financial statements
| Jun 2023 | 127.88M | 22.84M | 17.87% |
|---|---|---|---|
| Sep 2023 | 125.34M | 9.25M | 7.39% |
| Dec 2023 | 128.21M | 6.46M | 5.04% |
| Mar 2024 | 129.63M | 3.22M | 2.48% |
| Sep 2025 | 148.86M | 15.49M | 10.41% |
|---|---|---|---|
| Oct 2025 | 147.93M | 15.24M | 10.31% |
| Dec 2025 | 149.18M | 15.78M | 10.58% |
| Mar 2026 | 416.68M | 12.53M | 3.01% |
Analysts Price target
Financials & Ratios estimates
| 2024-04-24 | 0.16 | 0.19 |
|---|---|---|
| 2024-07-24 | 0.21 | 0.22 |
| 2024-10-23 | 0.23 | 0.25 |
0.23%
Yield TTM
| Payout ratio | 6.08% |
|---|
| 2019 | 5.84% |
|---|---|
| 2020 | 1.06% |
| 2021 | 0.18% |
| 2022 | 0.2% |
| 2023 | 0.23% |
| Jun 2023 | 601848000 | 382.24M | 63.51% |
|---|---|---|---|
| Sep 2023 | 592414000 | 362.96M | 61.27% |
| Dec 2023 | 586394999 | 356.58M | 60.81% |
| Mar 2024 | 587950000 | 350.53M | 59.62% |
| Jun 2023 | 8.78M | 1.21M | 1.21K |
|---|---|---|---|
| Sep 2023 | -215.93K | -3.41M | -6.03M |
| Dec 2023 | 19.26M | -2.38M | -18.38M |
| Mar 2024 | 5.53M | -1.65M | -4.08M |
Core Laboratories N.V. alternative data
| Aug 2023 | 3,600 |
|---|---|
| Sep 2023 | 3,600 |
| Oct 2023 | 3,600 |
| Nov 2023 | 3,600 |
| Dec 2023 | 3,600 |
| Jan 2024 | 3,600 |
| Feb 2024 | 3,600 |
| Mar 2024 | 3,600 |
| Apr 2024 | 3,600 |
| May 2024 | 3,500 |
| Jun 2024 | 3,500 |
| Jul 2024 | 3,500 |
Core Laboratories N.V. other data
97.89%
+2.45%
of CLB is owned by hedge funds
169
-21
45.32M
+760.63K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2019 | 5000 | 0 |
| Jan 2020 | 0 | 600 |
| Feb 2020 | 3000 | 0 |
| Apr 2020 | 769 | 1176 |
| May 2020 | 600 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | TEO SOW HANG officer: CAO & Treasurer | Restricted Shares | 576 | N/A | N/A | ||
Option | TEO SOW HANG officer: CAO & Treasurer | Common Stock | 576 | N/A | N/A | ||
Option | TEO SOW HANG officer: CAO & Treasurer | Restricted Shares | 250 | N/A | N/A | ||
Option | TEO SOW HANG officer: CAO & Treasurer | Common Stock | 250 | N/A | N/A | ||
Option | TATTOLI MARK DAMIAN officer: SVP, Gen Counsel & Sec.. | Common Stock | 700 | N/A | N/A | ||
Option | TATTOLI MARK DAMIAN officer: SVP, Gen Counsel & Sec.. | Restricted Shares | 700 | N/A | N/A | ||
Option | HILL CHRISTOPHER SCOTT officer: SVP & CFO | Common Stock | 36,072 | N/A | N/A | ||
Option | HILL CHRISTOPHER SCOTT officer: SVP & CFO | Common Stock | 36,072 | N/A | N/A | ||
Option | HILL CHRISTOPHER SCOTT officer: SVP & CFO | Performance Shares | 36,072 | N/A | N/A | ||
Option | HILL CHRISTOPHER SCOTT officer: SVP & CFO | Performance Shares | 36,072 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 25 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 1 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
U.S. Wide-Moat Stocks On Sale - The May 2024 Heat Map
U.S. Wide-Moat Stocks On Sale - The February 2024 Heat Map
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
U.S. Wide-Moat Stocks On Sale - The November 2023 Heat Map
Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts
Core Laboratories: Green Shoots, But Too Far Down The Road
Core Laboratories: A Pricey Oil Services Name At Technical Resistance
Core Laboratories: Likely To Take A Pause, Patience!
Weekly Oilfield Services Value And Momentum
-
What's the price of Core Laboratories N.V. stock today?
One share of Core Laboratories N.V. stock can currently be purchased for approximately $10.46.
-
When is Core Laboratories N.V.'s next earnings date?
Unfortunately, Core Laboratories N.V.'s (CLB) next earnings date is currently unknown.
-
Does Core Laboratories N.V. pay dividends?
Yes, Core Laboratories N.V. pays dividends and its trailing 12-month yield is 0.24% with 6% payout ratio. The last Core Laboratories N.V. stock dividend of $0.01 was paid on 7 Mar 2022.
-
How much money does Core Laboratories N.V. make?
Core Laboratories N.V. has a market capitalization of 802.14M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.1% to 509.79M US dollars. Core Laboratories N.V. earned 36.68M US dollars in net income (profit) last year or $0.25 on an earnings per share basis.
-
What is Core Laboratories N.V.'s stock symbol?
Core Laboratories N.V. is traded on the NYSE under the ticker symbol "CLB".
-
What is Core Laboratories N.V.'s primary industry?
Company operates in the Energy sector and Oil & Gas Equipment & Services industry.
-
How do i buy shares of Core Laboratories N.V.?
Shares of Core Laboratories N.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Core Laboratories N.V.'s key executives?
Core Laboratories N.V.'s management team includes the following people:
- Mr. Lawrence V. Bruno Chairman, Chief Executive Officer, Pres & Chief Operating Officer(age: 65, pay: $1,190,000)
- Mr. Christopher Scott Hill Senior Vice President & Chief Financial Officer(age: 55, pay: $548,030)
-
How many employees does Core Laboratories N.V. have?
As Jul 2024, Core Laboratories N.V. employs 3,500 workers, which is 3% less then previous quarter.
-
When Core Laboratories N.V. went public?
Core Laboratories N.V. is publicly traded company for more then 29 years since IPO on 21 Sep 1995.
-
What is Core Laboratories N.V.'s official website?
The official website for Core Laboratories N.V. is corelab.com.
-
How can i contact Core Laboratories N.V.?
Core Laboratories N.V. can be reached via phone at +31 20 420 3191.
Core Laboratories N.V. company profile:
Core Laboratories N.V.
corelab.comExchange:
NYSE
Full time employees:
3,500
Industry:
Oil & Gas Equipment & Services
Sector:
Energy
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Van Heuven Goedhartlaan 7 B
Amstelveen, 1181 LE
Amstelveen, 1181 LE
CIK: 0001000229
ISIN: US21867A1051
CUSIP: N22717107
